Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small nuclear ribonucleoprotein polypeptide G pseudogene 11 (SNRPGP11) is annotated as a pseudogene, meaning it is a non-functional DNA sequence resembling the protein-coding SNRPG gene. Unlike functional SNRPG, which encodes a core component of small nuclear ribonucleoproteins (snRNPs) essential for pre-mRNA splicing[3][4], SNRPGP11 does not produce a protein or contribute to molecular processes. At present, there are no known biological functions, disease associations, drug interactions, or clinical interest directly attributable to SNRPGP11. Its inclusion as a "target" is likely incorrect due to its non-coding, inactive status.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nuclear ribonucleoprotein polypeptide G pseudogene 11 (SNRPGP11).